Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole
Sponsor: Carnot Laboratories
Summary
The objective of this clinical trial is to compare which of the two drugs best resolves symptoms in patients diagnosed with erosive and non-erosive gastroesophageal reflux disease, adult males and females. The main question is What is the proportion of patients with resolution of the main symptoms of gastroesophageal reflux disease at four weeks of treatment with pantoprazole vs tegoprazan.
Official title: Multicenter, Active-controlled, Randomized, Double-blind, Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole: TOP-GERD
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
128
Start Date
2024-07-30
Completion Date
2025-11-30
Last Updated
2025-07-23
Healthy Volunteers
No
Conditions
Interventions
Tegoprazan
Tegoprazan 50 mg daily for 28 days
Pantoprazole
Pantoprazole 40 mg daily for 28 days
Locations (2)
Gastrologen S.A. de C.V.
Mexico City, Mexico City, Mexico
Saluz Investigación, S.C.
Boca del Río, Veracruz, Mexico